Kronox Lab Sciences is currently trading at Rs. 161.45, up by 0.60 points or 0.37% from its previous closing of Rs. 160.85 on the BSE.
The scrip opened at Rs. 161.90 and has touched a high and low of Rs. 166.65 and Rs. 160.00 respectively. So far 29103 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 200.55 on 11-Sep-2024 and a 52 week low of Rs. 138.00 on 16-Aug-2024.
Last one week high and low of the scrip stood at Rs. 177.10 and Rs. 160.00 respectively. The current market cap of the company is Rs. 599.23 crore.
The promoters holding in the company stood at 74.21%, while Institutions and Non-Institutions held 3.12% and 22.67% respectively.
Kronox Lab Sciences has received provisional consent from Gujarat Pollution Control Board (GPCB) for setting up an Industrial Plant at Dahej. The company has received all necessary statutory approvals from respective authorities which are necessary for Construction work of unit-IV at Dahej.
Approvals of construction plan, water supply connection, common solid waste disposal facility and common effluent treatment plant are also received from respective authorities. The process of setting up the new plant of the Company is working as per the schedule.
Kronox Lab Sciences is a bulk manufacturer of high purity fine chemicals, in compliance with Reagent, Pharmacopoeia and various Food Grade standards, for the pharmaceutical, nutraceutical, veterinary, food, chemical analysis and other specialty markets.
| Company Name | CMP |
|---|---|
| SRF | 2774.85 |
| BASF India | 3545.40 |
| Pidilite Inds. | 1598.15 |
| Tata Chemicals | 720.00 |
| Deepak Nitrite | 1642.55 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: